Breast cancer
Results
Phase 2
This trial was looking at adding ATN-224 to hormone therapy for breast cancer that had spread to another part of the body or had come back after treatment. It was for women who had hormone receptor positive breast cancer.
This trial was supported by Cancer Research UK.
Recruitment start: 19 June 2008
Recruitment end: 5 October 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Adrian Harris
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/08/043.
Last reviewed: 12 Jan 2016
CRUK internal database number: 888
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
